<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht004972.v2" study_id="phs000946.v4" participant_set="1" date_created="Fri Jan 10 13:34:41 2020"><description>Subject ID, consent group, and affection status of participants with or without chronic obstructive pulmonary disease and involved in the "NHLBI TOPMed: Boston Early-Onset COPD Study in the National Heart, Lung, and Blood Institute (NHLBI) Trans-Omics for Precision Medicine (TOPMed) Program" project.</description><variable id="phv00252862.v2"><name>SUBJECT_ID</name><description>Subject ID</description><type>string</type></variable><variable id="phv00252863.v2"><name>CONSENT</name><description>Consent group as determined by DAC</description><type>encoded value</type><value code="1">Disease-Specific (COPD and Smoking, RD) (DS-CS-RD)</value></variable><variable id="phv00252864.v2"><name>AFFECTION_STATUS</name><description>Case control status of the subject for severe, early-onset COPD</description><type>encoded value</type><value code="1">Control</value><value code="2">Case</value></variable></data_table>
